Canbridge Pharmaceuticals

CANBridge is a China-focused biopharmaceutical company developing specialty healthcare products for orphan diseases and targeted cancers.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
Series D
Initial Investment Year
2020
CA Nbridge Portco Hover Image